This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

LifeVantage Announces Leading Industry Scientists Strengthen Management Team And Scientific Advisory Board

Stocks in this article: LFVN

SALT LAKE CITY, June 30, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), the maker of science-based solutions for the reduction of oxidative stress by the synergistic activation of Nrf2, announced today that renowned scientist, co-discoverer of superoxide dismutase and a pioneer in the area of Free Radical Biology, Dr. Joe M. McCord, has accepted the position as the Company's Chief Scientific Officer.  In addition, Dr. Brooks Hybertson, nationally-recognized oxidative stress researcher, has been reappointed to the Company's Scientific Advisory Board.


Doug Robinson, LifeVantage CEO commented, "We are very pleased to announce Dr. McCord's appointment as Chief Scientific Officer and Dr. Hybertson's reappointment to our Scientific Advisory Board.  As published scientific researchers and faculty members at the University of Colorado, Denver, Dr. McCord and Dr. Hybertson are preeminent in the field of anti-aging, free radicals and oxidative stress, and we are honored to expand and continue our relationships with Dr. McCord and Dr. Hybertson.  The increased dedication we receive from these relationships with these renowned scientists as well as the many respected researchers conducting over 20 independent studies on Protandim®, complements our strategy for sound scientific products and our ability to positively influence the health of consumers everywhere. We look forward to our strengthened team increasing awareness of our breakthrough products based on true science for our existing and our next generation of consumers."

Dr. Joe McCord, LifeVantage Chief Scientific Officer, stated, "I am very excited to increase my role at LifeVantage as Chief Scientific Officer.  Our Company has been the beneficiary of many positive independent research reports from leading universities throughout the United States and we expect scientific research focus to continue to increase based on the attention the anti-aging industry is receiving.  My new role as CSO will focus on increasing awareness of our products in the scientific community as well as creating and promoting new high-quality, science-based products."

About LifeVantage Scientific Advisory Board

The Scientific Advisory Board provides input and advice regarding the technical research, intellectual property, and the internal and external education of LifeVantage products.  In addition, the Company has created the Chief Scientific Officer position to direct our Scientific Advisory Board to further align our strategic vision with our dedicated scientific staff.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,219.56 -197.29 -1.13%
S&P 500 2,004.00 -17.25 -0.85%
NASDAQ 4,652.9290 -30.4780 -0.65%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs